from Reuters: Company News https://ift.tt/2oDJoUK
Biotechnology firm ADC pulls listing amid latest IPO market jitters
Biotechnology company ADC Therapeutics SA postponed its planned $200 million U.S. initial public offering on Wednesday, citing adverse market conditions as it became the third company to pull a planned IPO in recent days.
from Reuters: Company News https://ift.tt/2oDJoUK
from Reuters: Company News https://ift.tt/2oDJoUK
Subscribe to:
Post Comments (Atom)
-
The German cabinet will hold a secret session on Wednesday to discuss safeguard measures regarding the possible participation of China's...
-
Stocks poised for another day of gains Equity markets look to add to the gains from the prior session as investor concerns about the fu...
-
By LIAM STACK from NYT Magazine https://ift.tt/2FNPp6k
No comments:
Post a Comment